(October 2, 2018, 2:10 PM EDT) -- BROOKLYN, N.Y. — Drug wholesaler AmerisourceBergen Corp. and four subsidiaries have agreed to pay $625 million to resolve civil allegations that they improperly repackaged cancer drugs into prefilled syringes, resulting in false claims, the U.S. Attorney’s Office for the Eastern District of New York announced Oct. 1....